Selective Versus Stepwise Removal of Deep Carious Lesions in Permanent Teeth Using Different Medicaments

September 3, 2024 updated by: Mohamed Ahmed Abdallah Rabiea, Al-Azhar University

Selective Versus Stepwise Removal of Deep Carious Lesions in Permanent Teeth Using Different Medicaments: An in Vivo Study

The study involved 54 adult patients between the ages of 18 and 50 years who had a posterior permanent tooth with a deep occlusal (Class I) carious lesion that extended to the inner third of the dentin (D3) and divided them into two equal groups randomly (N=27) according to the caries removal technique: group 1 (SE), and group 2 (SW). Then each main group was equally subdivided into three equal subgroups (n=9) according to the applied dentin dressing material as follows: Subgroup 1: Nano-silver compound (NSC), Subgroup 2: Chitosan-loaded nano hydroxy apatite (CS/N-HAp), Subgroup 3: Bioactive glass ionomer (N-BAG/GIC). At the first visit both groups received the same treatment of incomplete caries excavation, application of dentin dressing materials and sealing temporarily for 3-months with a glass ionomer cement (GIC). At the second visit the GIC reduced pulpally in (SE) group leaving 2 mm as base and completely removal the remaining carious lesion in (SW) group then re-application of same dentin dressing material on each tooth and GIC as a base. Finally, all cavities were restored with selective enamel etching technique, after which self-etch adhesive and Nano-filled composite resin are applied according to manufacturer instructions. The clinical and digital radiographic evaluations of the success and failure rates were performed at: baseline (7 days), 3, 12, and 18-months.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11651
        • Al Azhar University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Patients with first and second molars with occlusal deep carious lesions (Class I) extending to the inner third of dentin thickness on radiographic examination using (i-sensor H1, Woodpecker, China).
  2. Teeth with a healthy response to the electrical pulp tester (DY 310, Denjoy Dental CO., LTD, China).
  3. Teeth with the absence of spontaneous pain.
  4. Teeth with a negative sensitivity to percussion.
  5. Teeth with the absence of periapical lesions by a digital radiographic examination.
  6. Clinically, all teeth were without any mobility.
  7. Patients who will complete the procedure of follow up.
  8. Patients who will sign the consent.

Exclusion Criteria:

  1. Mutilated teeth or teeth with caries extending subgingivally.
  2. Teeth with the existence of previous restorations.
  3. Teeth with periodontal disease, any swelling, fistulas, signs of irreversible pulpitis or necrotic pulp.
  4. Teeth with roots showing external or internal resorption.
  5. Pregnant women.
  6. Presence of any systemic disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: selective removal (chitosan loaded nano hydroxyapatite )
selective removal then apply chitosan loaded nano hydroxyapatite
removal of all cavity caries except last layer related to the pulp
Experimental: selective removal (nano bioactive glass/GIC)
selective removal then apply (nano bioactive glass/GIC)
removal of all cavity caries except last layer related to the pulp
Experimental: selective removal (nanosilver)
selective removal then apply (nanosilver)
removal of all cavity caries except last layer related to the pulp
Experimental: stepwise removal (chitosan loaded nano hydroxyapatite )
stepwise removal then apply (chitosan loaded nano hydroxyapatite )
removal of all cavity caries except last layer related to the pulp
Experimental: stepwise removal (nano bioactive glass/GIC)
selective removal (nano bioactive glass/GIC)
removal of all cavity caries except last layer related to the pulp
Experimental: stepwise removal (nanosilver)
selective removal then apply (nanosilver)
removal of all cavity caries except last layer related to the pulp

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post operative pain
Time Frame: 7 days
evaluation of the post operative pain following restorations using modified USPHS
7 days
post operative pain
Time Frame: 3 months
evaluation of the post operative pain following restorations using modified USPHS
3 months
post operative pain
Time Frame: 12 months
evaluation of the post operative pain following restorations using modified USPHS
12 months
post operative pain
Time Frame: 18 months
evaluation of the post operative pain following restorations using modified USPHS
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

May 1, 2024

Study Completion (Actual)

August 1, 2024

Study Registration Dates

First Submitted

September 3, 2024

First Submitted That Met QC Criteria

September 3, 2024

First Posted (Estimated)

September 5, 2024

Study Record Updates

Last Update Posted (Estimated)

September 5, 2024

Last Update Submitted That Met QC Criteria

September 3, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2/9/2022

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries Arrested

Clinical Trials on partial caries removal

Subscribe